Eurofins Advinus Ltd (formerly Advinus Therapeutics Limited) is a premier R&D services company that supports the discovery and development of compounds for diverse industries including Pharmaceuticals, Biologicals, Nutraceuticals, Cosmetics, Medical Device, Specialty Chemicals and Agrochemicals. Our facility has over 25 years of GLP experience in conducting regulatory studies in compliance with global regulations for supporting clinical trials and registration of substances and products globally. Eurofins Advinus has been inspected twice by the USFDA for GLP studies submitted as part of IND packages. We have submitted 50+ complete IND packages globally. We have also conducted over 60 carcinogenicity studies and ~10,000 regulatory and non-regulatory studies for our global clients.Our Drug Discovery services include – Discovery chemistry ( Medicinal Chemistry / Synthetic Chemistry / Analytical Chemistry), Discovery Biology ( In Vitro Biology /In Vivo Pharmacology), DMPK/ADMET( In Vitro ADME Assays / In Vivo PK Studies / Discovery Bioanalysis) We offer end-to-end services in the areas of preclinical toxicology testing, chemical process development, analytical R&D, drug metabolism and pharmacokinetics for IND submission. In addition, the company also offers long term non-clinical toxicology testing, including carcinogenicity studies, in support of pharmaceutical new drug applications (NDA). We offer comprehensive services to support Agrosciences industry since 1992. These include Phys-chem, Residue, 5 batch, E-Fate and Regulatory Toxicology services to enable registration of its clients’ products globally. The studies are conducted in accordance with regulatory requirements of OECD, USEPA, EMA, ICH, JMAFF, ASTM, Brazilian, Indian CIB and other global guidelines.